U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta - Reuters

U.S. FDA approves Mylan generic of Lilly lung cancer drug Alimta  Reuters

(Reuters) - The U.S. Food and Drug Administration on Thursday granted Mylan NV tentative approval for its generic version of Eli Lilly and Co's lung cancer drug ...